journal article·2019-12-04Open access

Plastin 3 down-regulation augments the sensitivity of MDA-MB-231 cells to paclitaxel via the p38 MAPK signalling pathway

Yan Ma, Wenjia Lai, Minzhi Zhao, Chunyan Yue, Fanghao Shi, Ren Li, Zhiyuan Hu

Abstract

Plastin 3 (PLS3) overexpression may serve as a marker for predicting chemotherapeutic outcomes in drug-resistant cancer cells, but the mechanism is unclear. Herein, we show that the down-regulation of PLS3 by PLS3 gene silencing augments the sensitivity of MDA-MB-231 triple-negative breast cancer cells to paclitaxel. Interestingly, a low concentration of paclitaxel was able to induce strong apoptosis in the PLS3-silenced cells. Further study revealed that p38 MAPK signalling was responsible for the increased sensitivity to paclitaxel in these cells, as the p38 MAPK inhibitor SB203580 impaired the changes mediated by PLS3 down-regulation in response to paclitaxel. Therefore, our study identifies PLS3 as a potential target for enhancing the p38 MAPK-mediated apoptosis induced by paclitaxel. Unlike paclitaxel, Abraxane was unable to induce strong apoptosis in the PLS3-silenced cells. As PLS3 was found to be involved in the process of endocytosis in breast cancer cells, the reliance of cellular Abraxane uptake on this process may render it not as efficient as paclitaxel in PLS3-depleted tumour cells. The finding that PLS3 could be a critical regulator of paclitaxel sensitivity may have important implications for breast cancer chemotherapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cellular Mechanics and Interactions · Microtubule and mitosis dynamics · Cell Adhesion Molecules Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China

Sino-Danish College, University of Chinese Academy of Sciences

Academy for Advanced Interdisciplinary Studies, Peking University

University of Chinese Academy of Sciences

Center for Neuroscience Research, School of Basic Medical Sciences, Fujian Medical University

Funding

National Natural Science Foundation of China · Beijing Municipal Natural Science Foundation · Key Research Program of the Chinese Academy of Sciences

References (50)

Show source-provided references
1. 10.1002/j.1875-9114.1997.tb03813.x10.1002/j.1875-9114.1997.tb03813.x ↗
2. 10.1093/jnci/83.24.1797-a10.1093/jnci/83.24.1797-a ↗
3. 10.7326/0003-4819-111-4-27310.7326/0003-4819-111-4-273 ↗
4. 10.1056/NEJMoa07116710.1056/NEJMoa071167 ↗
5. 10.1016/S0140-6736(09)60740-610.1016/S0140-6736(09)60740-6 ↗
6. 10.1016/j.addr.2007.08.04410.1016/j.addr.2007.08.044 ↗
7. 10.1016/j.urolonc.2007.03.01510.1016/j.urolonc.2007.03.015 ↗
8. 10.1074/jbc.275.20.1483810.1074/jbc.275.20.14838 ↗
9. 10.1038/sj.onc.120406210.1038/sj.onc.1204062 ↗
10. 10.1006/excr.2001.526210.1006/excr.2001.5262 ↗
11. 10.1007/s11596-007-0628-610.1007/s11596-007-0628-6 ↗
12. 10.18632/oncotarget.694510.18632/oncotarget.6945 ↗
13. Sanchez-Prieto R, Rojas JM, Taya Y, et al. A role for the p38 mitogen-acitvated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents. Cancer Res. 2000;60:2464–2472.
14. Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994;9:1799–1805.
15. 10.1007/s11064-008-9659-z10.1007/s11064-008-9659-z ↗
16. 10.1083/jcb.86.1.33510.1083/jcb.86.1.335 ↗
17. 10.1016/S0021-9258(19)52543-110.1016/S0021-9258(19)52543-1 ↗
18. 10.1158/0008-5472.CAN-12-032610.1158/0008-5472.CAN-12-0326 ↗
19. 10.1038/bjc.2015.13210.1038/bjc.2015.132 ↗
20. 10.1016/S0014-5793(96)01150-710.1016/S0014-5793(96)01150-7 ↗
21. Ikeda H, Sasaki Y, Kobayashi T, et al. The role of T-fimbrin in the response to DNA damage: silencing of T-fimbrin by small interfering RNA sensitizes human liver cancer cells to DNA-damaging agents. Int J Oncol. 2005;27:933–940.
22. 10.1080/15548627.2015.107437210.1080/15548627.2015.1074372 ↗
23. 10.1016/j.canlet.2011.04.01410.1016/j.canlet.2011.04.014 ↗
24. 10.1038/sj.onc.120448710.1038/sj.onc.1204487 ↗
25. 10.1038/onc.2008.8210.1038/onc.2008.82 ↗
26. 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J ↗
27. 10.1016/j.jconrel.2013.05.04110.1016/j.jconrel.2013.05.041 ↗
28. Walle UK, Walle T. Taxol transport by human intestinal epithelial Caco-2 cells. Drug Metab Dispos. 1998;26:343–346.
29. 10.1002/j.1460-2075.1993.tb05947.x10.1002/j.1460-2075.1993.tb05947.x ↗
30. 10.1016/j.ajhg.2016.07.01410.1016/j.ajhg.2016.07.014 ↗
31. 10.1016/S0065-230X(04)92005-210.1016/S0065-230X(04)92005-2 ↗
32. Dolado I, Nebreda AR. Regulation of tumorigenesis by p38α MAP kinase. In: Posas F, Nebreda AR, editors. Stress-activated protein kinases. Topics in current genetics. Vol 20. Berlin–Heidelberg (Germany): Springer; 2007. p. 99–128.
33. 10.1158/0008-5472.CAN-09-163610.1158/0008-5472.CAN-09-1636 ↗
34. 10.1093/nar/15.15.596310.1093/nar/15.15.5963 ↗
35. 10.1016/j.canlet.2011.07.03210.1016/j.canlet.2011.07.032 ↗
36. 10.1074/jbc.M10503320010.1074/jbc.M105033200 ↗
37. 10.4161/cbt.2911410.4161/cbt.29114 ↗
38. Lamy V, Bousserouel S, Gosse F, et al. Lupulone triggers p38 MAPK-controlled activation of p53 and of the TRAIL receptor apoptotic pathway in human colon cancer-derived metastatic cells. Oncol Rep. 2011;26:109–114.
39. 10.1128/MCB.00050-0710.1128/MCB.00050-07 ↗
40. 10.1074/jbc.M51105220010.1074/jbc.M511052200 ↗
41. 10.1038/sj.cdd.440047610.1038/sj.cdd.4400476 ↗
42. Schnitzer JE. gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis. Am J Physiol. 1992;262:H246–H254.
43. 10.1083/jcb.150.5.105710.1083/jcb.150.5.1057 ↗
44. 10.1152/ajplung.2001.281.6.L151210.1152/ajplung.2001.281.6.L1512 ↗
45. Trieu V, Frankel T, Labao E, et al. SPARC expression in breast tumors may correlate to increased tumor distribution of nanoparticle albumin-bound paclitaxel (ABI-007) vs. taxol. Abstract in the Proceedings of the 96th Annual Meeting of the American Association for Cancer Research; 2005 Apr 16–20; Anaheim, CA. Cancer Res. 2005;65(9 Suppl):1314.
46. 10.1146/annurev.biochem.78.081307.11054010.1146/annurev.biochem.78.081307.110540 ↗
47. 10.1146/annurev-biochem-060910-09441610.1146/annurev-biochem-060910-094416 ↗
48. 10.1038/sj.gt.330269410.1038/sj.gt.3302694 ↗
49. 10.1245/s10434-013-3366-y10.1245/s10434-013-3366-y ↗
50. 10.1038/onc.2010.21510.1038/onc.2010.215 ↗